Stocks Resume Heavy Selling; Neurocrine Biosciences, Meta Platforms, NVO | Stock Market Today

TL;DR

Stocks experienced significant declines today, with major indexes like NASDAQ and S&P 500 down more than 1.5%. The market correction is ongoing, and investors are uncertain when the selling will taper off.

Transcript

thank you foreign good afternoon everyone and welcome to stock market today it's Ali Corman Ed Carson here with a look at the action in today's session where we saw stocks get hit hard again today Ed yeah it was not a fun session once again uh and I do want to take a look at three stocks that are holding up reasonably well neurocrine biosciences me... Read More

Key Insights

• 🫰 The market correction continues, with major indexes and individual stocks experiencing significant declines.
• 😮 Treasury yields are rising, which poses challenges for the market's rebound.
• 🥹 Mega-cap tech stocks are struggling, with only a select few holding up well.
• 🖐️ The metaverse concept and the shift to AI development tools may play a role in the future of companies like Meta.
• 📈 Energy stocks, such as NOV, may offer opportunities in the market, as long as oil prices continue to trend upward.
• 🙃 Investors should consider taking partial profits along the way with stocks like NOV, as their volatility and past performance suggest potential ups and downs.

Questions & Answers

Q: When can we expect the selling pressure in the market to ease?

The market outlook remains uncertain, and it is challenging to predict when the selling will let up. While there may be short-term bounces, investors should wait for a follow-through day to confirm a rebound.

Q: What factors are contributing to the rising treasury yields?

The rising treasury yields are likely influenced by factors such as government shutdown concerns, a stronger US economy, and the normalization of interest rates after an extended period of unusually low rates.

Q: How is the strong US dollar affecting companies with overseas operations?

The strong US dollar can be a headwind for companies with significant overseas operations. When these companies bring back their profits to the US, the currency exchange negatively impacts their earnings.

Q: Is it advisable to invest in biotech stocks during this market environment?

Biotech stocks like NBIX have been relatively insulated from economic concerns and have shown strength recently. However, caution is necessary, as biotech stocks can have volatile movements and significant losses.

Summary & Key Takeaways

• Major indexes like NASDAQ, S&P 500, and Russell 2000 saw declines of around 1-1.6% in today's session.

• The market correction is persisting, with the NASDAQ approaching the 13,000 level and the S&P 500 nearing its 200-day line.

• The Dow closed below its 200-day line for the first time since Q1 of this year, reflecting the breadth weakness in the market.

• Treasury yields continue to rise, putting further pressure on the market.

• The US dollar remains strong, which can negatively impact companies with significant overseas operations.